[Modalities of treatment of Parkinsonian syndrome with L-dopa].
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Modalités de la thérapeutique du syndrome Parkinsonien par la L-dopa.